ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,994.57
      -0.76%
      US Tech 100
      20,867.60
      -0.11%
      Dow Jones
      44,421.91
      -0.28%
      Brent Oil
      75.155
      -0.27%
      Bitcoin
      98,704.03
      -2.68%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Vranken Pommery Monopole Sa (0J7D) Quote

      Vranken Pommery Monopole Sa

      Vranken Pommery Monopole Sa (0J7D)

      LSE
      23.20
      0.00
      (0.00%)
      Closed February 04 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      23.20
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      23.20 52 Week Range 23.20
      Market Cap
      207.338M
      Previous Close
      23.20
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      22
      Shares Outstanding
      8,937,000
      Dividend Yield
      -
      PE Ratio
      18.39
      Earnings Per Share (EPS)
      0.69
      Revenue
      341.89M
      Net Profit
      6.15M

      About Vranken Pommery Monopole Sa

      Sector
      Wine,brandy & Brandy Spirits
      Industry
      Wine,brandy & Brandy Spirits
      Website
      www.vrankenpommery.com
      Headquarters
      Reims, Marne, Fra
      Founded
      -
      Vranken Pommery Monopole Sa is listed in the Wine,brandy & Brandy Spirits sector of the London Stock Exchange with ticker 0J7D. The last closing price for Vranken Pommery Monopole was 23.20 €. Over the last year, Vranken Pommery Monopole shares have traded in a share price range of 23.20 € to 23.20 €.

      Vranken Pommery Monopole currently has 8,937,000 shares outstanding. The market capitalization of Vranken Pommery Monopole is 207.34 € million. Vranken Pommery Monopole has a price to earnings ratio (PE ratio) of 18.39.

      Ask ADVFN Intelligence (AI)

      0J7D Latest News

      More News

      VRANKEN-POMMERY MONOPOLE - COMMUNIQUE FINANCIER Chiffre d’affaires consolidé 2024 : 302,9 M€

      VRANKEN-POMMERY MONOPOLE - COMMUNIQUE FINANCIER Chiffre d’affaires consolidé 2024 : 302,9 M€ COMMUNIQUE FINANCIER Chiffre d’affaires consolidé 2024 : 302,9 M€ CHIFFRE D’AFFAIRES CONSOLIDE...

      January 28 2025
      UK Regulatory

      Vranken-Pommery Monopole - FINANCIAL PRESS RELEASE - Consolidated turnover for 2024 : € 302,9 million

      Vranken-Pommery Monopole - FINANCIAL PRESS RELEASE - Consolidated turnover for 2024 : € 302,9 million FINANCIAL PRESS RELEASE Consolidated turnover for 2024 : € 302,9 million CONSOLIDATED...

      January 28 2025
      UK Regulatory

      Statement of the number of actions and voting rights in 24.12.31

      Statement of the number of actions and voting rights in 24.12.31 January 16th, 2025                                  Monthly publication of the number of shares comprising the share capital and...

      January 16 2025
      UK Regulatory

      VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 31.12.2024

      VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 31.12.2024 Le 16 janvier 2025                         Publication mensuelledu nombre d’actions composant le capital...

      January 16 2025
      UK Regulatory

      Repeat: COMMUNIQUE FINANCIER : Evolution de la gouvernance du Groupe Vranken-Pommery Monopole

      Repeat: COMMUNIQUE FINANCIER : Evolution de la gouvernance du Groupe Vranken-Pommery Monopole COMMUNIQUE FINANCIER Evolution de la gouvernance du Groupe Vranken-Pommery Monopole Reims, le 16...

      December 17 2024
      UK Regulatory

      Repeat: FINANCIAL PRESS RELEASE : Governance Evolution of the Vranken-Pommery Monopole Group

      Repeat: FINANCIAL PRESS RELEASE : Governance Evolution of the Vranken-Pommery Monopole Group FINANCIAL PRESS RELEASE Governance Evolution of the Vranken-Pommery Monopole Group Reims, December...

      December 17 2024
      UK Regulatory

      FINANCIAL PRESS RELEASE : Governance Evolution of the Vranken-Pommery Monopole Group

      FINANCIAL PRESS RELEASE : Governance Evolution of the Vranken-Pommery Monopole Group FINANCIAL PRESS RELEASE Governance Evolution of the Vranken-Pommery Monopole Group Reims, December 16, 2024...

      December 16 2024
      UK Regulatory

      COMMUNIQUE FINANCIER : Evolution de la gouvernance du Groupe Vranken-Pommery Monopole

      COMMUNIQUE FINANCIER : Evolution de la gouvernance du Groupe Vranken-Pommery Monopole COMMUNIQUE FINANCIER Evolution de la gouvernance du Groupe Vranken-Pommery Monopole Reims, le 16 décembre...

      December 16 2024
      UK Regulatory

      VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 31.10.2024

      VRANKEN-POMMERY MONOPOLE : nombre total de droits de vote et d'actions au 31.10.2024 Le 22 novembre 2024                            Publication mensuelledu nombre d’actions composant le...

      November 22 2024
      UK Regulatory

      Statement of the number of actions and voting rights in 24.11.31

      Statement of the number of actions and voting rights in 24.11.31 November 22th, 2024                              Monthly publication of the number of shares comprising the share capital and the...

      November 22 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10023.223.223.220323.2DE
      40023.223.223.26323.2DE
      120023.223.223.22223.2DE
      260023.223.223.21023.2DE
      520023.223.223.2523.2DE
      1560023.223.223.2323.2DE
      2600023.223.223.2223.2DE

      0J7D - Frequently Asked Questions (FAQ)

      What is the current Vranken Pommery Monopole share price?
      The current share price of Vranken Pommery Monopole is 23.20 €
      How many Vranken Pommery Monopole shares are in issue?
      Vranken Pommery Monopole has 8,937,000 shares in issue
      What is the market cap of Vranken Pommery Monopole?
      The market capitalisation of Vranken Pommery Monopole is EUR 207.34M
      What is the 1 year trading range for Vranken Pommery Monopole share price?
      Vranken Pommery Monopole has traded in the range of 23.20 € to 23.20 € during the past year
      What is the PE ratio of Vranken Pommery Monopole?
      The price to earnings ratio of Vranken Pommery Monopole is 18.39
      What is the cash to sales ratio of Vranken Pommery Monopole?
      The cash to sales ratio of Vranken Pommery Monopole is 0.33
      What is the reporting currency for Vranken Pommery Monopole?
      Vranken Pommery Monopole reports financial results in EUR
      What is the latest annual turnover for Vranken Pommery Monopole?
      The latest annual turnover of Vranken Pommery Monopole is EUR 341.89M
      What is the latest annual profit for Vranken Pommery Monopole?
      The latest annual profit of Vranken Pommery Monopole is EUR 6.15M
      What is the registered address of Vranken Pommery Monopole?
      The registered address for Vranken Pommery Monopole is 5 PLACE GENERAL GOURAUD, B.P. 1049, REIMS, MARNE, 51100
      What is the Vranken Pommery Monopole website address?
      The website address for Vranken Pommery Monopole is www.vrankenpommery.com
      Which industry sector does Vranken Pommery Monopole operate in?
      Vranken Pommery Monopole operates in the WINE,BRANDY & BRANDY SPIRITS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 68.35
      (0.00%)
      		675
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 68.35
      (0.00%)
      		675
      0R2VApple Inc
      $ 228.50
      (0.00%)
      		5.78k
      0HCIAlibaba Group Holding Ltd
      $ 95.50
      (0.00%)
      		5.73k
      0R0XTesla Inc
      $ 384.40
      (0.00%)
      		5.02k
      ROADRoadside Real Estate Plc
      30.20p
      (0.00%)
      		3.5k
      0T3WBilibili Inc
      $ 0.00
      (0.00%)
      		2.38k

      Discussion

      View Full Feed
      jog49 jog49 7 minutes ago
      "Why is the fhfa wings not cut yet while cfpb alone was?"

      Source of funding, I would say.
      FNMA
      The_Pro The_Pro 9 minutes ago
      I would rather DewmBoom back versus Claytrader. Oldies will know him.

      Great asset to this board.
      BIEL
      Researchfyi Researchfyi 11 minutes ago
      So tell me. What has the company done for investors repetitiously?

      I would tell you the answers, but I love to hear your carry the water for them replies.

      Then again you know the answers from reading my posts.
      LQMT
      diamondguru-one diamondguru-one 12 minutes ago
      New-WMI IPO offering to UQ escrow holders from the WMI-LT in Plan 6/DST/DCR.

      The Possibility;
      +$40/1.215 = $32.9 opening share price.
      MC =+$40 Billion in hard assets

      what's your thoughts on the share ratio ???

      1 for 1
      5 for 1
      COOP
      jog49 jog49 12 minutes ago
      "We need to message ackman and tell him to shut the Fudge up about the warrants"

      Thank you!
      FNMA
      DruidOracle55 DruidOracle55 12 minutes ago
      1 million years
      AXXA
      benz280e benz280e 13 minutes ago
      Fully reporting for 2025, on Melvins typical no communication procrastination calendar could very well mean March 15, 2026, more than an entire year from now, if ever at all...
      GDVM
      RickNagra RickNagra 14 minutes ago
      Oh wow.  Incoming $$99 on deck.  Of oh wow amazing I will be a millionaire or maybe more hard to say in these times and the future is always going to be better for me.  DBMM is a great project and company to own and support the community and the team is very strong.  Best to win and own millions of
      DBMM
      nowwhat2 nowwhat2 14 minutes ago
      https://investorshub.advfn.com/uimage/uploads/2025/2/4/vzkfptot_@_3_6m_11pm_bounce_then_whump.jpg




      XRP 2.50 Baby.........HODL the bucking bronco !

      https://investorshub.advfn.com/uimage/uploads/2025/2/4/ftxmxXRP_@_3_TRIO_930PM_100K_250_WHUMP.jpg
      XRPUSD
      pgsd pgsd 17 minutes ago
      US biosimilar 'void' spells trouble as biologic patent expirations loom, IQVIA report says :
      February 3, 2025

      While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for biosimilar developers may not materialize b
      NWBO
      ham n slam ham n slam 19 minutes ago
      people keep mentioning the high end piece of tail babs."..keep in mind 36 mil shares is one percent of the float...Emil holds 1 bil so 2.5 bil is out there on the garage sale table. alot of shares, imo..my gut tells me she can sell but why?hang on babs! you don't need a new wardrobe just yet!! chill
      VPLM
      oldmystic oldmystic 21 minutes ago
      5.64 yes https://invst.ly/18qz13
      https://media.stocktwits-cdn.com/api/3/media/1740042/medium.jpeg
      AVXL
      Investor082 Investor082 23 minutes ago
      It’s funny how conversations always shift to manipulators or what retailers should do rather than what LP and the management team does for the shareholders. If they do not have non dilutive funds lined up after 4.5 years post data lock, and almost 3 years since TLD then LP has failed shareholders. N
      NWBO
      IceCold8 IceCold8 25 minutes ago
      Some of us are filing complaints https://www.finra.org/investors/need-help/file-a-complaint I thought the market was bad under FJB, I'm thinking it's going to be even worse under this one,and I'm hoping I'm seriously wrong!
      CGAC
      doccjc doccjc 35 minutes ago
      Great,,, I had sent a message on X,,, glad they fixed it,,
      I can't get over the 80% reduction in tumor size and metastatic activity in 30 days !
      RDGL
      bbotcs bbotcs 38 minutes ago
      mankind: Greenland 51st State, not Canada!
      dinogreeves dinogreeves 38 minutes ago
      Market is reversing into positive territory, reversing 80 point loss on Nasdaq, must be something cooking with these two super powers.
      SMCI
      bbotcs bbotcs 40 minutes ago
      Gmenfan: Well the victims of the procedures will be able to sue her down the road.
      nowwhat2 nowwhat2 40 minutes ago
      When did he post that ?.......

      https://investorshub.advfn.com/uimage/uploads/2025/2/4/dkzyqeth_@_3_duo_11pm_trump_said_buy_when.jpg


      Answer - YUP !



      Guy shouldn't even be ALLOWED to run around posting chit like that !

      ETHUSD
      bbotcs bbotcs 41 minutes ago
      lj: I think Trump is looking at a U.S.-Canadian merger. Canada is a political Disneyland. This would be a good time for Quebec to go indy.
      bbotcs bbotcs 42 minutes ago
      lj: I think it was cancelled for this area. Film at 11.
      mikepgator mikepgator 44 minutes ago
      Nevermind, I emailed and got confirmation that it has been fixed.
      RDGL
      quester614 quester614 44 minutes ago
      WRONG AGAIN. The consolidated statements of operations, also known as the income statement ARE found in the AUDITED FINANCIALS. So what's your point. That's not where your posted statement came from. TRY AGAIN post link and page #. LOLOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/2/4/qny
      XERI
      mikepgator mikepgator 51 minutes ago
      Unless I’m not reading it correctly, it seems like there is a word missing here, if anyone has contact with someone at the company to fix it before the PR goes out.

      “remained at the point of injection and no adverse ??? reported by any of the initial five patients since the initial tr
      RDGL
      Nrdc92 Nrdc92 53 minutes ago
      Chs, I would argue that pps resiliency is solely down to limited float and LWLG's inclusion in the Russell 3000. Not due to any belief by anyone in the promise of LWLG. If any of those two factors breakdown - e.g., LWLG booted from the Russell in June, something that's highly likely IMO - this dog g
      LWLG

      Your Recent History

      LSE
      0J7D
      Vranken Pommery Monopole
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads